An in vitro study of drug displacement interactions: warfarin-salicylate and warfarin-phenylbutazone
- PMID: 37303
- DOI: 10.1111/j.2042-7158.1979.tb13509.x
An in vitro study of drug displacement interactions: warfarin-salicylate and warfarin-phenylbutazone
Abstract
The binding interactions between warfarin-salicylate and warfarin-phenylbutazone in the presence of 4 g percent bovine serum albumin at 37 degrees C were studied using equilibrium dialysis. Methods of representing and analysing drug binding interactions are discussed. Scatchard plots, double reciprocal plots and the like are shown to be of no use in representing drug displacement interactions since they display only one drug and they can be potentially misleading. It is argued that a preferable method of analysing drug displacement interaction data is in terms of a stepwise multiple equilibria model. The numerical problems associated with fitting this kind of model to the data are discussed. A three-dimensional representation of the binding surface is proposed as a superior means of visualizing drug displacement interactions.
Similar articles
-
Albumin-binding interactions of sodium valproate.J Clin Pharmacol. 1980 Aug-Sep;20(8-9):514-7. doi: 10.1002/j.1552-4604.1980.tb02544.x. J Clin Pharmacol. 1980. PMID: 6776162
-
Drug-binding properties of rat alpha-foetoprotein. Specificities of the phenylbutazone-binding and warfarin-binding sites.Biochem J. 1986 Oct 15;239(2):451-8. doi: 10.1042/bj2390451. Biochem J. 1986. PMID: 2434073 Free PMC article.
-
Spectrophotofluorometric evidence of negatively cooperative binding of warfarin and phenylbutazone to human serum albumin.Life Sci. 1980 Jan 21;26(3):173-9. doi: 10.1016/0024-3205(80)90291-x. Life Sci. 1980. PMID: 7360001 No abstract available.
-
[Bovine serum albumin binding of various anti-inflammatory agents].Folia Med Cracov. 1979;21(1):165-71. Folia Med Cracov. 1979. PMID: 396191 Review. Polish. No abstract available.
-
Interaction of phenylbutazone and colchicine in binding to serum albumin in rheumatoid therapy: 1H NMR study.Spectrochim Acta A Mol Biomol Spectrosc. 2009 Sep 15;74(1):1-9. doi: 10.1016/j.saa.2009.06.043. Epub 2009 Jun 25. Spectrochim Acta A Mol Biomol Spectrosc. 2009. PMID: 19615934 Review.
Cited by
-
Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.Clin Pharmacokinet. 1987 Jun;12(6):402-32. doi: 10.2165/00003088-198712060-00002. Clin Pharmacokinet. 1987. PMID: 3301150 Review.
-
Plasma protein binding and interaction studies with piroxicam.Naunyn Schmiedebergs Arch Pharmacol. 1984 Aug;327(1):81-5. doi: 10.1007/BF00504996. Naunyn Schmiedebergs Arch Pharmacol. 1984. PMID: 6493354
-
Protein binding displacement interactions and their clinical importance.Drugs. 1983 May;25(5):495-513. doi: 10.2165/00003495-198325050-00003. Drugs. 1983. PMID: 6345130 Review.
-
Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography.J Chromatogr A. 2009 Apr 17;1216(16):3492-500. doi: 10.1016/j.chroma.2008.09.080. Epub 2008 Oct 1. J Chromatogr A. 2009. PMID: 18926542 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources